Empagliflozin in the treatment of heart failure with preserved ejection fraction

被引：1
|
作者：
Morbach, C. [1 ]
Frantz, S. [1 ]
Nitschmann, S.
机构：
[1] Univ Klinikum Wurzburg, Med Klin & Poliklin 1, Deutsch Zentrum Herzinsuffizienz, Wurzburg, Germany
来源：
INNERE MEDIZIN | 2022年 / 63卷 / 07期
关键词：
D O I：
10.1007/s00108-022-01345-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：808 / 809
页数：2
相关论文
共 50 条
  • [31] Advances in the treatment of heart failure with a preserved ejection fraction
    Das, Aparajita
    Abraham, Selwin
    Deswal, Anita
    [J]. CURRENT OPINION IN CARDIOLOGY, 2008, 23 (03) : 233 - 240
  • [32] Treatment of patients with heart failure and preserved ejection fraction
    Deswal A.
    Bozkurt B.
    [J]. Current Treatment Options in Cardiovascular Medicine, 2008, 10 (6) : 516 - 528
  • [33] Diagnosis and treatment of heart failure with preserved ejection fraction
    辛坤丽
    张金国
    [J]. South China Journal of Cardiology, 2015, 16 (03) : 193 - 200
  • [34] Nicotinamide for the treatment of heart failure with preserved ejection fraction
    Abdellatif, Mahmoud
    Trummer-Herbst, Viktoria
    Koser, Franziska
    Durand, Sylvere
    Adao, Rui
    Vasques-Novoa, Francisco
    Freundt, Johanna K.
    Voglhuber, Julia
    Pricolo, Maria-Rosaria
    Kasa, Michael
    Turk, Clara
    Aprahamian, Fanny
    Herrero-Galan, Elias
    Hofer, Sebastian J.
    Pendl, Tobias
    Rech, Lavinia
    Kargl, Julia
    Anto-Michel, Nathaly
    Ljubojevic-Holzer, Senka
    Schipke, Julia
    Brandenberger, Christina
    Auer, Martina
    Schreiber, Renate
    Koyani, Chintan N.
    Heinemann, Akos
    Zirlik, Andreas
    Schmidt, Albrecht
    von Lewinski, Dirk
    Scherr, Daniel
    Rainer, Peter P.
    von Maltzahn, Julia
    Muhlfeld, Christian
    Kruger, Marcus
    Frank, Sasa
    Madeo, Frank
    Eisenberg, Tobias
    Prokesch, Andreas
    Leite-Moreira, Adelino F.
    Lourenco, Andre P.
    Alegre-Cebollada, Jorge
    Kiechl, Stefan
    Linke, Wolfgang A.
    Kroemer, Guido
    Sedej, Simon
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (580)
  • [35] Pharmacological Treatment of Heart Failure with Preserved Ejection Fraction
    Yamamoto, Kazuhiro
    [J]. YONAGO ACTA MEDICA, 2017, 60 (02) : 71 - 76
  • [36] Treatment of Hypertension in Heart Failure with Preserved Ejection Fraction
    ul Haq, Muhammad Asrar
    Hare, David L.
    Wong, Chiew
    Hayat, Umair
    Barlis, Peter
    [J]. CURRENT HYPERTENSION REVIEWS, 2014, 10 (03) : 142 - 148
  • [37] Ivabradine for Treatment of Heart Failure With Preserved Ejection Fraction
    Babushkina, G. V.
    Shaykhlislamova, G. I.
    [J]. KARDIOLOGIYA, 2020, 60 (10) : 33 - 37
  • [38] Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction EMPEROR-Preserved Trial
    Packer, Milton
    Butler, Javed
    Zannad, Faiez
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Carson, Peter
    Anand, Inder
    Doehner, Wolfram
    Haass, Markus
    Komajda, Michel
    Miller, Alan
    Pehrson, Steen
    Teerlink, John R.
    Schnaidt, Sven
    Zeller, Cordula
    Schnee, Janet M.
    Anker, Stefan D.
    [J]. CIRCULATION, 2021, 144 (16) : 1284 - 1294
  • [39] Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age
    Boehm, Michael
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Abdin, Amr
    Mahfoud, Felix
    Brueckmann, Martina
    Gollop, Nicholas D.
    Iwata, Tomoko
    Ponikowski, Piotr
    Wanner, Christoph
    Zannad, Faiez
    Packer, Milton
    Anker, Stefan D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (01) : 1 - 18
  • [40] EMPEROR-Preserved: Empagliflozin and Outcomes in Heart Failure with a Preserved Ejection Fraction and Chronic Kidney Disease
    Wanner, Christoph
    [J]. INTERNIST, 2022, 63 (SUPPL 3): : 349 - 349
12345